Results
1
These companies have already demonstrated past earnings growth, and analysts are forecasting further income growth. We've excluded mining and oil stocks because they are very cyclical.
1 companies
argenx
Market Cap: €41.5b
argenx SE, ein Biopharma-Unternehmen im kommerziellen Stadium, entwickelt verschiedene Therapien zur Behandlung von Autoimmunkrankheiten in den Vereinigten Staaten, Japan, China, den Niederlanden und international.
ARGX
€684.40
7D
1.1%
1Y
18.2%